Related references
Note: Only part of the references are listed.Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study
Russell Blair Egerdie et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Attenuated Proliferation and Trans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment of Benign Prostatic Hyperplasia
Christoph Zenzmaier et al.
ENDOCRINOLOGY (2010)
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target
Stina Haggstrom Rudolfsson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Hypoxia-reoxygenation promotes aggressive phenotype in prostate cancer cells
Lakshmipathi Khandrika et al.
JOURNAL OF UROLOGY (2008)
Early sildenafil dose optimization and personalized instruction improves the frequency, flexibility, and success of sexual intercourse in men with erectile dysfunction
C. P. Steidle et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
Ejaculation frequency and subsequent risk of prostate cancer
MF Leitzmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Sexual factors and prostate cancer
GG Giles et al.
BJU INTERNATIONAL (2003)
Share Paper
